[HTML] springer.comFull View

[HTML][HTML] The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia, RJ Vassar - Molecular neurodegeneration, 2023 - Springer
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …
被引用次数：89 相关文章

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia… - Molecular …, 2023 - search.proquest.com
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia… - Molecular …, 2023 - scholars.northwestern.edu
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored.

S Chandra, SS Sisodia… - Molecular …, 2023 - search.ebscohost.com
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …
[HTML] biomedcentral.com

[HTML][HTML] The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia… - Molecular …, 2023 - molecularneurodegeneration …
Alzheimer's disease (AD), the most common cause of dementia, results in a sustained
decline in cognition. There are currently few effective disease modifying therapies for AD …
[HTML] nih.gov

[HTML][HTML] The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia, RJ Vassar - Molecular Neurodegeneration, 2023 - ncbi.nlm.nih.gov
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

The gut microbiome in Alzheimer's disease: What we know and what remains to be explored

S Chandra, SS Sisodia… - Molecular …, 2023 - knowledge.uchicago.edu
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia… - Molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD), the most common cause of dementia, results in a sustained
decline in cognition. There are currently few effective disease modifying therapies for AD …

The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, S Sisodia, R Vassar - Molecular Neurodegeneration, 2023 - europepmc.org
Abstract Alzheimer's disease (AD), the most common cause of dementia, results in a
sustained decline in cognition. There are currently few effective disease modifying therapies …
[HTML] biomedcentral.com

[HTML][HTML] The gut microbiome in Alzheimer's disease: what we know and what remains to be explored

S Chandra, SS Sisodia… - Molecular …, 2023 - molecularneurodegeneration …
Alzheimer's disease (AD), the most common cause of dementia, results in a sustained
decline in cognition. There are currently few effective disease modifying therapies for AD …